Punished for the Sin of Not Raising: With Red Hat Reaccelerating and the Multiple Reset, We Upgrade IBM Back to Outperform
Key Takeaways
- IBM beat both lines (revenue $15.92B, +6% cc, vs. ~$15.77B; operating EPS $1.91 vs. ~$1.81, up 19%) with 140 bps of operating pre-tax margin expansion and free cash flow up 13% to $2.2B, the highest first-quarter cash generation in a decade, and still the stock fell 8.3% to $231.08, a new 52-week-low zone.
- The sell-off was about the guide, not the quarter: management reiterated rather than raised its 2026 outlook, which the CFO noted IBM has never done in a first quarter. Underneath, the full-year Software guide was actually nudged up to "10-plus percent" and the Data guide to "low-20s," so the reiteration is conservatism, not a warning.
- The one thing we most wanted to see happened: Red Hat reaccelerated two points sequentially to +10% cc as consumption-based services stabilized, reversing the deceleration that troubled us last quarter. Data grew 16% cc, IBM Z posted another record (+48% cc), and Consulting signings returned to growth (+6%) even as its revenue lagged at +1% cc.
- Confluent closed early (mid-March), goodwill jumped to $74.7B and debt to $66.4B, and the CEO offered the clearest articulation yet of why AI is a tailwind rather than a threat: roughly 96% of IBM's software is enabling/infrastructure software, not the application and interaction layer where agents will erode value.
- Rating: Upgrading to Outperform from Hold. Two of the three re-upgrade triggers we set in January have fired: a meaningful pullback that restores a margin of safety (the stock is down ~26% from its January peak to roughly 18x forward operating earnings, a ~7% free-cash-flow yield), and Red Hat reaccelerating back to double digits. At this valuation the market is pricing the AI-disruption threat and ignoring IBM as an AI beneficiary; we think that is backward, and we buy the overdone sell-off.
Results vs. Consensus
| Metric | Actual | Consensus | Beat/Miss | Magnitude |
|---|---|---|---|---|
| Revenue | $15.92B | ~$15.77B | Beat | +1.0% |
| Software revenue | $7.05B | ~$7.0B | Beat | +8% cc |
| Consulting revenue | $5.27B | ~$5.25B | In line | +1% cc |
| Infrastructure revenue | $3.33B | ~$3.1B | Beat | +12% cc |
| Operating gross margin | 57.7% | ~56.9% | Beat | +110 bps |
| Operating pre-tax margin | 13.4% | ~12.4% | Beat | +140 bps |
| Operating EPS | $1.91 | $1.81 | Beat | +5.5% |
| Free cash flow (Q1) | $2.2B | n/a | +13% Y/Y | Record Q1 margin |
Year-over-Year Comparison
| Metric | Q1 2026 | Q1 2025 | Y/Y | Y/Y (cc) |
|---|---|---|---|---|
| Total revenue | $15,917M | $14,541M | +9% | +6% |
| Software | $7,052M | $6,336M | +11% | +8% |
| Consulting | $5,272M | $5,068M | +4% | +1% |
| Infrastructure | $3,326M | $2,886M | +15% | +12% |
| Operating pre-tax margin | 13.4% | 12.0% | +140 bps | n/a |
| Operating EPS | $1.91 | $1.60 | +19% | n/a |
| Adjusted EBITDA margin | 25.0% | 23.4% | +170 bps | n/a |
Assessment
Revenue. Six percent constant-currency growth on top of a strong prior-year comp, with Software and Infrastructure both double-digit reported, is a clean start to the year, and management raised the full-year Software guide to "10-plus percent" on the back of it. The optical software deceleration to 8% cc is a seasonal-mix artifact, not a demand signal: the recurring base ($24.6B ARR, up 10%) accelerated, and the transactional software that inflates Q4 simply is not present in Q1. This is a case where the reported number reads worse than the underlying trend.
Margins and cash. Operating pre-tax margin expanded 140 bps and adjusted EBITDA margin reached 25.0% (up 170 bps), both ahead of plan and achieved while absorbing incremental Confluent dilution from the early close. Free cash flow of $2.2B (up 13%) is a record first-quarter margin and keeps the ~$15.7B full-year target comfortably in reach. The productivity flywheel is intact and, importantly, is what let management hold the margin guide despite pulling Confluent forward.
Why the stock fell anyway. None of the above is what moved the tape. The stock fell because a market that had already marked IBM down 15% for the year wanted a guidance raise to break the AI-disruption narrative, and did not get one. Management's refusal to raise a first-quarter guide it has never raised is prudence, not a warning, but into weak sentiment the absence of a positive catalyst became the catalyst. That gap between a genuinely good quarter and a poor reaction is the opportunity.
Segment Performance
| Segment | Revenue | Y/Y (rep) | Y/Y (cc) | Segment margin | Notable |
|---|---|---|---|---|---|
| Software | $7,052M | +11.3% | +7.9% | 29.8% | Red Hat +10% cc (reaccel); Data +16% cc; ARR $24.6B (+10%) |
| Consulting | $5,272M | +4.0% | +0.9% | 10.6% | Signings +6% (returned to growth); GenAI ~30% of backlog |
| Infrastructure | $3,326M | +15.3% | +11.7% | 15.8% | IBM Z +48% cc (record); margin +720 bps; guided down in FY |
| Financing | $220M | +14.8% | +10.2% | 53.8% | Receivables ~80% investment grade |
Key portfolio KPIs
| KPI | This Q | Trend | Read |
|---|---|---|---|
| Software ARR | $24.6B | +10% Y/Y | Reaccelerated to double-digit growth |
| Software AI/agent ARR | >$1.5B | +40%+ | ~2 pts of software growth; multiplier over time |
| Consulting GenAI ARR | >$4B | Accelerating | ~30% of backlog; 80% from net-new clients |
| OpenShift ARR | $2.0B | ~high-20s% | Virtualization >$600M signed since 2024 |
| Consulting signings | +6% Y/Y | Returned to growth | 400 new clients; leading indicator turning |
Software (+8% cc): the seasonal step-down that isn't a slowdown
Software grew 8% cc, optically down from Q4's 11% but, per management, entirely a function of transactional mix (roughly 30% of Q4 software is transactional versus 10% in Q1); the recurring annuity base accelerated to a $24.6B ARR growing 10%. Red Hat was the standout, reaccelerating two points sequentially to +10% cc as consumption-based services stabilized, with OpenShift now a $2B ARR business growing in the high-20s. Data grew 16% cc (with Confluent closing mid-March), Automation grew 7% cc as it lapped the HashiCorp anniversary, and Transaction Processing grew 2% cc, its second quarter of growth on the z17 monetization cycle.
"Red Hat growth accelerated 2 points sequentially to 10%, largely driven by the stabilization of consumption-based services revenue growth that we expected." — James Kavanaugh, CFO
Assessment: The Red Hat reacceleration is the single most important data point for our rating, directly reversing the Q4 deceleration and the federal-bookings drag. Management raised the full-year Software guide to "10-plus percent" and the Data guide to the low-20s, which is not the behavior of a company seeing softness. The seasonal-mix explanation for the 8% optical print is credible and consistent with the accelerating ARR.
Infrastructure (+12% cc): a record Q1, then the planned digestion
Infrastructure grew 12% cc with IBM Z up 48% cc, a record, marking four straight quarters of 100%-plus MIPS growth on z17; Distributed Infrastructure also grew double-digits on Power and storage strength. Segment pre-tax margin expanded a remarkable 720 bps. Management reiterated the full-year Infrastructure guide of down low-single-digits (about a half-point drag to IBM) as the cycle digests through the back half, while stressing the software tail: the record MIPS placement monetizes as Transaction Processing, storage attach, and maintenance over the next one to two years.
"We monetize that value based on how many MIPS are shipped in the market and for 4 quarters in a row, on z17, we've shipped over 100% growth of new MIPS in the market, including first quarter." — James Kavanaugh, CFO
Assessment: Infrastructure remains the known 2026 headwind, but Q1's record and the 720 bps of margin expansion show the cycle is aging from a position of strength. The new AI-inferencing vector (running fraud models on 100% of transactions via Spyre, versus 10% sampling) is a genuine incremental monetization path that could make the guided decline conservative.
Consulting (+1% cc): revenue lags, but the leading indicator turns
Consulting revenue grew 1% cc, still the portfolio laggard, but signings returned to growth (+6%) with strength in application and data-transformation work, GenAI now roughly 30% of backlog and a $4B-plus GenAI ARR run-rate, and 400 new clients added in the quarter. Segment margin declined modestly on currency and reinvestment. Management held the full-year guide of low-to-mid single-digit growth.
"Signings returned to growth, up 6% with strength across our application and data transformation offerings, driven by clients modernizing their environments to support AI adoption." — James Kavanaugh, CFO
Assessment: The signings inflection is the encouraging tell that the AI-disruption fear on consulting is overstated: clients are hiring IBM to deploy AI, not cutting the relationship. Revenue conversion lags signings, so +1% cc understates the momentum. We still treat Consulting as a modest contributor, but the leading indicators argue against the value-trap narrative the market is pricing.
Key Topics & Management Commentary
Overall Management Tone: Management was confident and, unusually, spent much of the call playing offense against the AI-disruption thesis rather than defending the quarter. The CEO delivered his most detailed articulation to date of why IBM's software mix (enabling and infrastructure software, not applications) is a beneficiary rather than a casualty of the agent era. The one deliberately conservative note was the guidance, which management framed as first-quarter prudence, three months into a dynamic year, rather than any observed weakness, explicitly stating pipeline and demand signals showed no slowdown.
Why AI is a tailwind, not a threat
The defining topic of the call was the AI-disruption debate. The CEO framed IBM as roughly 96% enabling/infrastructure software (only Maximo, ~4%, is an application), positioned in the durable data, business-logic, and infrastructure layers rather than the interaction layer where agents will erode value. As enterprises move AI from experimentation to scale on their own governed data, consumption of Red Hat, Confluent, automation, and the mainframe rises.
"Value is going to decrease in that interaction layer because as agents replace people for some fraction ... the interaction layer by itself is not sticky. The agents are going to be interacting much more with the underlying data and the business logic. And we sort of saw that coming 6, 7 years ago, and that is why we picked the portfolio we did." — Arvind Krishna, CEO
Assessment: This is the most important strategic argument in the report and, in our view, the correct one. The market is applying an application-software-disruption discount to a company that deliberately exited applications and sits in the layers that AI consumes more of. If that framing is right, the current multiple is a mispricing, which is the core of the upgrade.
The 2026 software acceleration to 10-plus percent
Management raised the full-year Software guide from 10% to "10-plus percent," with Data now expected in the low-20s (Confluent contributing a bit over 15 points of that segment's growth, the rest organic), Red Hat contributing ~2.5 points to IBM, Automation on-model, and Transaction Processing monetizing the z17 cycle.
"We talked about entering the year 10% growth. Now we see it growing 10-plus percent accelerating. ... we now see data up low 20-plus percent range. That's going to deliver 5 points of software growth." — James Kavanaugh, CFO
Assessment: Raising the software segment guide while holding the total-company guide is the tell that the reiteration is conservatism, not caution. Software is the load-bearing driver for 2026, and management is more confident on it than a quarter ago, which materially de-risks the whole-company outlook despite the Infrastructure digestion.
The mainframe as an AI inference platform
Management detailed a genuinely new mainframe monetization vector: with the Spyre accelerator, clients can run 20-to-30-billion-parameter models in-line on 100% of transactions (versus sampling ~10% off-platform), enabling real-time fraud detection that saves tens of millions of dollars. Clients using watsonx Code Assistant for Z are growing MIPS capacity 3x faster than those who are not.
"What happens if you could run a 20 billion, 30 billion parameter model right on the mainframe ... you can do that to every single transaction. So if you can take your fraud rate down from 50 basis points to 40, you can now do the math on what that is." — Arvind Krishna, CEO
Assessment: This reframes the mainframe from a legacy asset into an AI-inference platform with a fresh capacity-and-software monetization cycle. It is the strongest argument that the Infrastructure guide-down is conservative and that the z-stack multiplier extends well into 2027.
Confluent closes early
Confluent closed in mid-March, roughly two months ahead of the assumed mid-May timing, driving the Data guide higher but also pulling forward dilution. IBM invested $10.5B in acquisitions in the quarter, lifting goodwill to $74.7B and debt to $66.4B, while accelerating cost synergies to hold the ~1-point full-year margin guide.
"While we are absorbing incremental dilution given the early closing of Confluent, actions we are taking to accelerate our cost synergies enable us to stay on track to expand operating pretax margins by about 1 point this year." — James Kavanaugh, CFO
Assessment: The early close is a modest positive for revenue and a modest near-term drag on margin, netting to neutral on the year given the synergy acceleration. The balance-sheet expansion (goodwill now nearly half of assets) is the item to keep watching, but IBM's free cash flow comfortably services the debt, as the 31st consecutive dividend increase underscores.
Productivity flywheel keeps funding the model
The productivity program has delivered $4.5B of savings since 2023 with another $1B expected in 2026, and it is what let IBM absorb the early Confluent dilution without cutting the margin guide. Project Bob (now generally available and used by the entire IBM developer workforce at 45% average productivity gains) is the flagship internal proof point.
"Since 2023, this has driven $4.5 billion of productivity savings, with an additional $1 billion expected in 2026. Our success is enabling us to accelerate investments in innovation ... and fuel our growth flywheel while expanding our margins." — James Kavanaugh, CFO
Assessment: The productivity engine remains the most durable, macro-independent pillar, and its role in offsetting Confluent dilution this quarter is a concrete demonstration of the flexibility it provides. It underwrites the margin and free-cash-flow guides regardless of the revenue mix.
M&A appetite rises as software valuations fall
The CEO signaled that the broad de-rating in software valuations has opened IBM's appetite for further deals, potentially in the second half once Confluent integration is well underway and cash rebuilds, while cautioning that sellers may take time to accept the new price levels.
"The values that are out there right now are very attractive. ... that does open up our appetite perhaps more than it would in a normal year ... maybe we can do something in the second half as we build up our cash balances." — Arvind Krishna, CEO
Assessment: IBM's disciplined M&A machine buying into a software downturn is a rational, value-additive use of its cash flow, and the HashiCorp precedent (EBITDA-accretive ahead of plan within a year) supports the execution case. The watch item remains balance-sheet discipline after a $10.5B quarter, but the framework and track record are sound.
Guidance & Outlook
| Metric (FY2026) | Prior guide (Q4) | New guide (Q1) | Change |
|---|---|---|---|
| Revenue growth (cc) | More than 5% | More than 5% | Maintained |
| Software growth | ~10% | 10-plus percent | Raised |
| Data growth (within Software) | ~high teens | Low-20s | Raised (Confluent early close) |
| Infrastructure growth | Down low-single-digits | Down low-single-digits | Maintained |
| Consulting growth | Low-to-mid single digit | Low-to-mid single digit | Maintained |
| Operating pre-tax margin exp. | ~+1 pt | ~+1 pt | Maintained |
| Free cash flow | ~$15.7B (+~$1B) | ~$15.7B (+~$1B) | Maintained |
The headline is that total-company guidance was held, which the market read as a disappointment, but the composition improved: Software was raised to "10-plus percent" and Data to the low-20s, offset by the unchanged Infrastructure digestion. Management was explicit that the reiteration reflects first-quarter prudence with more than 85% of free cash flow still to come, not any observed weakness, and pointed to strong Q1 demand in the Middle East (the strongest in decades) and Europe.
Q2 2026 shape: Management guided Q2 cc revenue growth similar to the full year (~5%+) and operating pre-tax margin expansion of about 50 bps, the lighter margin step reflecting the pull-forward of Confluent dilution before the full synergy ramp.
Street at: The reiterated >5% cc revenue and ~$15.7B free-cash-flow guides sit against a consensus that had been fading toward the low end of the range on AI-disruption worries; the raised Software segment guide is the underappreciated positive.
Guidance style: Textbook IBM conservatism. The CFO explicitly recalled that a year ago, on the same call, the same question produced the same first-quarter reiteration, after which IBM raised through the year and beat in Q4. The pattern strongly suggests the >5% cc guide embeds cushion, and the market's punishment of the non-raise is a misread of a company that structurally under-promises in Q1.
Analyst Q&A Highlights
Where AI value accrues in the software stack
The opening question asked the CEO to frame IBM's software mix (infrastructure vs. applications, subscription vs. consumption) and where AI value accrues. The answer was the strategic centerpiece of the call: ~96% enabling/infrastructure software, almost entirely consumption-tied, positioned in the layers AI consumes more of as enterprises scale on their own data.
Q: "As AI adoption really scales, where in that stack do you see the most incremental value accruing to IBM versus the ecosystem? ... how you think of software, the puts and takes in the AI-centric world."
— Amit Daryanani, Evercore ISI
A: "If they're using data from the internal systems, many parts of our portfolio, be it Red Hat, be it Confluent, will come to be consumed more and more. ... this is a tailwind because of the model that we picked. ... we very consciously over the last 7 years driven the portfolio into this." — Arvind Krishna, CEO
Assessment: The most consequential exchange of the call. Management is making an evidence-backed case (visible in the mainframe consumption numbers) that AI structurally increases demand for IBM's portfolio. If the market eventually accepts this framing, the current discount closes.
Why not raise guidance after a beat?
The exchange the tape cared about most: with a clean beat and better-than-expected free cash flow, why hold the guide, and is management seeing anything concerning in Europe? The CEO said there was no slowdown, the strongest Middle East quarter in decades, and strong Europe, framing the reiteration purely as three-months-in prudence; the CFO invoked IBM's never-raise-in-Q1 track record.
Q: "Are you seeing something in Europe that keeps you at bay right now? Are you seeing evidence of something slowing that keeps you from raising guidance? ... the free cash flow was better than expected in the quarter. Why not raise it?"
— Ben Reitzes, Melius Research
A: "I've been in this role now 9 years, Arvind's been in the role 6, 7 years. I don't think we've ever raised guidance in the first quarter. ... dial back a year ago, same call, same question ... We took up free cash flow throughout the year, and then we blew through it in the fourth quarter." — James Kavanaugh, CFO
Assessment: The answer is dispositive for our rating. Management explicitly denied seeing any slowdown, cited record and strong demand in two regions, and grounded the reiteration in a consistent multi-year pattern. The market punished process, not fundamentals, which is precisely the kind of dislocation an upgrade should exploit.
The software constant-currency step-down
A pointed question on the optical software deceleration (11% cc in Q4 to 8% in Q1) drew a clear seasonal-mix explanation: transactional software is ~30% of the Q4 mix versus ~10% in Q1, so the entire three-point step-down is mix, while the core annuity actually accelerated.
Q: "Last year, 9% growth in Q1 ... 11% in Q4. So investors are asking, you're seeing a little bit of a downtick. Is that due to seasonality ...?"
— Brent Thill, Jefferies
A: "The entire 3-point drop quarter-to-quarter is the fundamentals of the mix of the portfolio. In fourth quarter ... about 30% ... is transactional. In the first quarter, that's about 10%. When you look at the underpinnings of the core annuity by itself, we're actually accelerating." — James Kavanaugh, CFO
Assessment: A clean, quantified answer that defuses the deceleration worry. The accelerating annuity and the raised full-year software guide corroborate it; the 8% print is a calendar artifact, not a trend.
Mainframe AI inferencing and TP monetization cadence
A question on the mix shift toward non-traditional AI workloads on the mainframe and the Transaction Processing monetization cadence drew a detailed answer on the new AI-inference capacity layer and the 3-4x stack multiplier that follows each hardware dollar over the cycle.
Q: "What type of a workload mix are you seeing today that you would consider conventionally mainframe? And what is that velocity of potential mix shift? ... how should [TP and MIPS growth] transpire ... in terms of the growth cadence?"
— Fatima Boolani, Citigroup
A: "We just anniversaried our first full year of z17 ... We've increased hardware placement value by over $1 billion. ... you think about the future monetization opportunity ... That's that 3 to 4x multiplier that will play out over time. A big chunk of that being our TP software." — James Kavanaugh, CFO
Assessment: The AI-inference layer is a real, incremental monetization vector, and the quantified $1B+ higher placement value versus the record z16 program frames a multi-year software and services tail. It is the strongest reason to view the Infrastructure guide-down as conservative.
Memory costs and supply-chain exposure
Asked how IBM is managing memory-cost and supply-chain headwinds, the CFO characterized the impact as de minimis given IBM's ~75% human-capital/IP and ~45% software mix, with hardware only ~25% of revenue, and pointed to the segment's 720 bps of margin expansion as evidence the company is managing it, while flagging RHEL (tied to enterprise hardware placements) as the one area to monitor.
Q: "How material is memory within the infrastructure base? How are you mitigating? How are customers responding? How does it impact your outlook on growth and margins?"
— Erik Woodring, Morgan Stanley
A: "It has a de minimis impact to us overall. ... Will it impact storage and potentially some components of our distributed infrastructure, absolutely. But ... we've been in existence for 115, 116 years ... we know how to run global supply chains." — James Kavanaugh, CFO
Assessment: A reasonable framing given IBM's software-weighted mix, and the 720 bps of infrastructure margin expansion supports it. RHEL is the legitimate watch item, but memory costs are a second-order issue for a business that is three-quarters services and IP.
Winning regardless of the GenAI application-layer victor
The closing exchange probed how IBM positions to win regardless of who wins the GenAI application layer, given its deliberately low application exposure. The CEO reiterated the "Switzerland" model-neutral strategy, working with all frontier and open models while owning the data, governance, and deployment layers beneath them.
Q: "How are you setting IBM up to win kind of regardless of what ends up being the winner of the GenAI application layer? And what kind of investments does that take?"
— Matt Swanson, RBC Capital Markets
A: "We made the decision about 3 years ago that we were going to be neutral and Switzerland like also on our usage of frontier models. ... whichever model you want to use, you can use. And wherever you want to run them, we'll help you run them. ... a good half of the world is interested in that paradigm." — Arvind Krishna, CEO
Assessment: The model-neutral, own-the-plumbing strategy is coherent and consistent with IBM's decades-long positioning. It sidesteps the frontier-model capex arms race entirely, which is the right posture for a company whose edge is enterprise trust, governance, and integration rather than model performance.
What They're NOT Saying
- A raised total-company guide: Despite raising the Software and Data segment guides, management held the consolidated revenue and free-cash-flow guides. The explanation (Q1 prudence) is credible, but the refusal to let the software raise flow through to the total is the conservatism the market chose to punish.
- The standalone AI revenue metric: As promised in January, IBM retired the GenAI book-of-business disclosure, now describing AI in ARR and contribution terms ($1.5B+ software AI ARR, $4B+ consulting GenAI ARR). The framing is more useful, but it ends the clean cumulative series just as the AI debate peaks.
- The all-in Confluent economics and total debt trajectory: Management quantified 2026 dilution (~$600M plus early-close increment) but was light on the total consideration and how the $66.4B debt and $74.7B goodwill balances evolve as further second-half M&A is contemplated.
- A firm RHEL stabilization timeline: RHEL was flagged as the watch item (federal-signings and hardware-supply sensitivity), but management gave no specific quarter for it to reaccelerate, leaving it as the residual soft spot inside a reaccelerating Red Hat.
- Second-half M&A specifics: The CEO opened the door to opportunistic deals in a de-rated software market but offered no targets, size, or financing plan, leaving the capital-allocation path (and its balance-sheet implications) deliberately open.
Market Reaction
- Pre-print setup: IBM entered at $251.86, already down 15.0% year-to-date 2026 and roughly 19% below its January peak near $315, on AI-disruption worries and the 2026 deceleration narrative. The 52-week closing range was $223.35 to $314.98, so the stock was near the low end entering the print.
- Reaction session (April 23): Shares fell 8.3% to $231.08 ($20.78), gapping down 7.8% at the open and trading as low as $221.73 before closing near the lows. Volume of 22.3M was 4.6x the 30-day average, a decisive repricing that pushed the stock into fresh 52-week-low territory.
- Context: The S&P 500 was roughly flat (-0.4%) on the session, so the decline was entirely IBM-specific.
This is the second time in our coverage that IBM has beaten and been sold hard (the first was Q2 2025, also on a technicality), and the pattern is instructive: into weak sentiment, a market looking for a reason to sell will take the absence of a guidance raise as that reason. The difference this time is the price. In July 2025 the stock was near all-time highs at ~24x forward; today it is near a 52-week low at ~18x forward with a ~7% free-cash-flow yield and a freshly raised dividend. Selling a beat-and-hold quarter down to a 52-week low, while management raises the software guide and denies any demand slowdown, is the kind of sentiment-driven dislocation that creates the asymmetry we want. The tape is pricing the AI-disruption bear case as if it were confirmed; the fundamentals say the opposite.
Street Perspective
Debate: Is AI a structural threat to IBM or a tailwind?
Bull view: The bull case, which management pressed hard, is that IBM sits in the enabling-software, data, and infrastructure layers that AI consumes more of as enterprises scale on their own governed data, with almost no exposure to the application/interaction layer agents will disrupt; the mainframe consumption numbers already show the tailwind.
Bear view: The bear camp contends AI commoditizes middleware and, more pointedly, cannibalizes the labor-based consulting that has long anchored IBM's client relationships, capping growth and justifying a permanent discount to software peers.
Our take: We side firmly with the bulls at this price. The consulting-cannibalization worry is real but overstated, signings just returned to +6% growth and GenAI is now a third of the backlog, and the software portfolio is deliberately positioned in the durable layers. The market is applying an application-disruption multiple to a company that exited applications; that is the mispricing the upgrade targets.
Debate: Does the reiterated guide signal caution?
Bull view: The bulls note IBM never raises in Q1, that management explicitly denied any slowdown (record Middle East, strong Europe), that it raised the Software and Data segment guides, and that the same pattern last year preceded through-the-year raises and a Q4 beat; the reiteration is conservatism.
Bear view: The bears argue that a management confident in its year would have raised after a clean beat and better-than-expected cash flow, and that holding the guide amid rising macro uncertainty hints at second-half caution management is not yet voicing.
Our take: The bull reading is better supported. The segment-guide raises, the explicit no-slowdown language, and the documented never-raise-in-Q1 pattern make the reiteration a process choice, not a signal. If anything, the raised software guide against a held total is a coiled spring for through-the-year raises, exactly the setup that preceded 2025's Q4 beat.
Debate: Is the valuation a value trap or a genuine dislocation?
Bull view: At ~18x forward operating earnings, a ~7% free-cash-flow yield, and a 2.9% dividend just raised for the 31st straight year, IBM is priced for stagnation despite double-digit software growth, record free cash flow, and expanding margins; the de-rating from ~25x has created a genuine dislocation.
Bear view: The bears counter that IBM has spent a decade as a value trap that periodically looks cheap and then re-derates lower as growth disappoints, and that the AI overhang could keep the multiple compressed regardless of the fundamentals.
Our take: The value-trap history is real and it is why our conviction is a 6, not a 9. But the IBM of 2026 is a different business than the shrinking one of the mid-2010s: software is 45%-plus of revenue and growing double digits, free cash flow is at record levels, and the dividend is well covered. At ~18x with those characteristics and a raised software guide, the risk/reward has genuinely inflected, and the downside is anchored by the cash flow and yield. This is a dislocation, not a trap.
Model Update Needed
| Item | Prior assumption | Suggested change | Reason |
|---|---|---|---|
| FY26 revenue growth (cc) | ~5-5.5% | ~5.5-6% | Strong Q1; software guide raised; bias to beat |
| FY26 Software growth | ~10% | 10-plus percent | Management raise; Data to low-20s on Confluent |
| FY26 operating EPS | ~$12.5-12.8 | ~$12.6-12.9 | 140 bps Q1 margin beat; +19% EPS |
| FY26 free cash flow | ~$15.7B | ~$15.7B+ | Record Q1; management beat-bias |
| Fair-value multiple | ~23-25x | ~21-23x forward | De-rate acknowledges AI overhang; still > current 18x |
Valuation impact: At the post-print $231.08, IBM trades at roughly 18x our ~$12.7 FY26 operating EPS and a ~7% free-cash-flow yield, near a 52-week low. Even on a conservatively de-rated 21-23x forward multiple (a discount to where it traded for most of 2025), fair value sits around $270-290, implying roughly 17-25% price upside plus a 2.9% dividend. That is a wide enough gap, anchored by the free-cash-flow yield, to clear our Outperform bar with room to spare.
Thesis Scorecard Post-Earnings
| Thesis Point | Status | Notes |
|---|---|---|
| Bull #1: Software mix + ARR compounding drives durable growth | Confirmed | ARR $24.6B (+10%, reaccelerated); FY software guide raised to 10-plus%; Data to low-20s |
| Bull #2: Self-funded productivity flywheel expands margins | Confirmed | +140 bps pre-tax margin; $4.5B savings + $1B more in 2026; absorbed Confluent dilution |
| Bull #3: z17 mainframe cycle + platform multiplier | Neutral | IBM Z +48% cc record; new AI-inference vector; but Infrastructure still guided down in FY |
| Bull #4: Best-in-class free cash flow + rising dividend | Confirmed | Record Q1 FCF (+13%); ~7% FCF yield; 31st straight dividend increase to $1.69 |
| Bull #5 (new): AI is a tailwind, not a threat, to IBM's enabling-software mix | Confirmed | ~96% enabling/infra software; consumption rising with AI scale; consulting signings +6% |
| Bear #1: Growth is M&A-assisted | Contained | Confluent adds ~15 pts of Data growth; but Red Hat/TP reaccel is organic |
| Bear #2: Consulting structurally pressured by AI | Challenged | Revenue +1% cc but signings returned to +6%; GenAI ~30% of backlog, $4B ARR |
| Bear #3: Full valuation limits upside | Challenged | De-rated from ~25x to ~18x forward; the bear point that drove the Q4 downgrade has reversed |
| Bear #4: Red Hat deceleration + reset ambition | Challenged | Red Hat reaccelerated +2 pts to +10% cc on consumption-services stabilization |
Overall: Thesis strengthened and, critically, re-priced. The two concerns that drove our January downgrade have both reversed: the full valuation has de-rated ~26% to ~18x forward, and Red Hat reaccelerated back to double digits. Meanwhile the emerging bear worry, AI-disruption of consulting, is being actively challenged by a +6% signings return and management's articulate repositioning of IBM as an AI beneficiary.
Action: Upgrade to Outperform from Hold. This is a valuation-and-catalyst upgrade: buy the overdone, sentiment-driven sell-off in a business whose software is reaccelerating, whose free cash flow is at record levels, and whose ~7% free-cash-flow yield and 2.9% growing dividend anchor the downside. We would revisit on evidence of a genuine demand slowdown (which management explicitly denied), a Red Hat relapse, or a debt-financed acquisition that stresses the balance sheet; we would move back to Hold if the stock re-rated toward the mid-20s forward without a further step-up in growth.